Daniil Gataulin
Stock Analyst at Chardan Capital
(4.75)
# 261
Out of 4,996 analysts
112
Total ratings
58.42%
Success rate
48.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Buy | $35 → $76 | $54.31 | +39.94% | 8 | Sep 25, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.46 | +379.45% | 14 | Sep 19, 2025 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $21 | $12.53 | +67.60% | 1 | Sep 15, 2025 | |
| TRML Tourmaline Bio | Downgrades: Neutral | $70 → $48 | $47.74 | +0.54% | 4 | Sep 10, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.65 | +438.86% | 13 | Sep 8, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $0.97 | +209.25% | 10 | Aug 28, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $13.84 | +340.75% | 6 | Aug 15, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $2.41 | +314.94% | 1 | Aug 15, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.19 | +327.61% | 5 | Aug 15, 2025 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $33 | $4.51 | +631.71% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $8.28 | +81.16% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.33 | +200.75% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $13.90 | +94.24% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.04 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $33 | $17.68 | +86.70% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.60 | +36,597.25% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.80 | - | 2 | Jul 25, 2023 |
uniQure
Sep 25, 2025
Maintains: Buy
Price Target: $35 → $76
Current: $54.31
Upside: +39.94%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.46
Upside: +379.45%
Ocular Therapeutix
Sep 15, 2025
Initiates: Buy
Price Target: $21
Current: $12.53
Upside: +67.60%
Tourmaline Bio
Sep 10, 2025
Downgrades: Neutral
Price Target: $70 → $48
Current: $47.74
Upside: +0.54%
REGENXBIO
Sep 8, 2025
Maintains: Buy
Price Target: $52
Current: $9.65
Upside: +438.86%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $0.97
Upside: +209.25%
Forte Biosciences
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $13.84
Upside: +340.75%
Zura Bio
Aug 15, 2025
Maintains: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
MeiraGTx Holdings
Aug 15, 2025
Maintains: Buy
Price Target: $35
Current: $8.19
Upside: +327.61%
Adverum Biotechnologies
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $4.51
Upside: +631.71%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.28
Upside: +81.16%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.33
Upside: +200.75%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $13.90
Upside: +94.24%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.04
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $28 → $33
Current: $17.68
Upside: +86.70%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.60
Upside: +36,597.25%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $15.80
Upside: -